It may be early to call it consolidation in e-pharmacy space, but PharmEasy has just acquired Medlife in what could be one of the biggest deals in this nascent space. PharmEasy is already a unicorn meaning a company with a market valuation of more than $1 billion. The total value of the transaction has not been disclosed but estimates have put the valuation of Medlife at around $250 million.
Post the merger, all the Medlife customers will become PharmEasy customers and the porting will be absolutely seamless except a change in the interface. The combined entity of PharmEasy and Medlife will service nearly 2 million customers every month. PharmEasy will also onboard Medlife retail partners into the platform.
It may be early to call it consolidation in e-pharmacy space, but PharmEasy has just acquired Medlife in what could be one of the biggest deals in this nascent space. PharmEasy is already a unicorn meaning a company with a market valuation of more than $1 billion. The total value of the transaction has not been disclosed but estimates have put the valuation of Medlife at around $250 million.
Post the merger, all the Medlife customers will become PharmEasy customers and the porting will be absolutely seamless except a change in the interface. The combined entity of PharmEasy and Medlife will service nearly 2 million customers every month. PharmEasy will also onboard Medlife retail partners into the platform.